Seoul, South Korea

Youngjun Lee

This inventor holds 14 USPTO granted patents and 8 published patent applications and 17 EPO patents, primarily in Heating Technology. Top assignees: Lg Electronics Inc., Chonnam National University, Paean Biotechnology Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Youngjun Lee. Retrieved from https://idiyas.com/inventor/youngjun-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 71.4

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Air Conditioner
Natural Killer Cell
Carbon Composite
Carbon Heater
Surface Heater
Mobile Terminal
Cooking Device
Glass Composition
Enamel Composition
Oxidation Protective Layer
Image Preview Screen
Pharmaceutical Composition
14 patents (USPTO):Explore Patents

Title: Youngjun Lee: Innovator in Immunotherapy

Introduction

Youngjun Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunotherapy, particularly through his innovative research and development of natural killer (NK) cell therapies. With a total of 14 patents, Lee's work is paving the way for advancements in the treatment of infectious diseases and cancer.

Latest Patents

One of Youngjun Lee's latest patents focuses on a natural killer cell containing exogenous mitochondria and a pharmaceutical composition comprising the same. This invention provides NK cells and peripheral blood mononuclear cells (PBMC) that exhibit increased cytotoxicity. The introduction of exogenous mitochondria into these cells enhances the immune system's ability to combat infectious diseases and cancer. As a result, the NK cells and PBMC can be utilized in compositions aimed at the prevention or treatment of these conditions. Notably, the use of autogenous NK cells and PBMC ensures stability without triggering an immune reaction, which is expected to lead to high commercial viability.

Career Highlights

Throughout his career, Youngjun Lee has worked with notable companies such as LG Electronics Inc. and Paean Biotechnology Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and immunotherapy.

Collaborations

Some of Youngjun Lee's coworkers include Wanho Ju and Namjin Kim, who have collaborated with him on various projects related to his innovative research.

Conclusion

Youngjun Lee's contributions to immunotherapy through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in the treatment of serious health conditions, showcasing the potential of innovative therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…